1-6 of 372 Activities
Pre-exposure prophylaxis (PrEP) is an established and highly effective method of preventing sexually transmitted human immunodeficiency virus (HIV) infections and has been instrumental in declining incidence rates. Adherence and access to HIV prevention still pose challenges due to stigma and false beliefs, and the small fraction of individuals with HIV who are unaware of their status are responsible for a significant number of new cases. Clinicians and multidisciplinary care teams must familiarize themselves with new data on emerging PrEP options to increase optimal and equitable HIV prevention as well as to engage with patients about sexual health in meaningful and compassionate ways.
In this CME Outfitters livestream symposium, expert faculty will guide learners on the implementation of routine HIV testing and on adopting a status-neutral approach to effectively promote prevention strategies and PrEP initiation. Faculty will evaluate current and emerging PrEP options, introduce emerging LAI PrEP options, and discuss optimal patient selection criteria, transitioning strategies, and monitoring considerations. Faculty will model integration of effective patient engagement strategies to collaboratively initiate PrEP treatment and support adherence.
In this CME Outfitters live webcast, expert faculty will discuss the role of FcRn in the pathogenesis of gMG, evaluate the safety and efficacy of FcRn antagonists for the treatment of gMG, and provide expert guidance on how to identify patients with gMG who may be appropriate candidates for treatment with FcRn antagonists. Finally, they will model development of optimized and individualized treatment plans for patients with gMG receiving FcRn antagonists, providing learners with key skills to bring back to clinical practice.
In this Efficient CME livestream symposium, expert faculty will examine and share best practices for interpreting and reporting PET imaging in early AD and provide opportunities to test your skills using a highly interactive format to help improve real-world practices.
This CMEO digital monograph highlights an educational activity focused on the 2022 CDC Guideline for Prescribing Opioids for Chronic Pain, changes made since the last Guideline published in 2016, and strategies to utilize the updated recommendations in the real-world management of pain. Emphasis will be placed on the need to individualize treatment to the needs of the patient, integrating multi-modal pain management strategies, understanding the different pain pathways, and addressing the biopsychosocial factors that influence each patient’s experience of pain.
In this interactive infographic activity, an expert faculty in the science and clinical implementation of vaccines provides the foundation for empathetic, evidence-based discussions with patients and caregivers, addressing concerns and promoting informed decision-making. Strengthening these skills is vital to sustaining immunization programs, preventing outbreaks of vaccine-preventable diseases, and ensuring the health and well-being of communities worldwide.
In this CME Outfitters recorded symposium, faculty will examine the role of pro-inflammatory cytokines in the pathogenesis of IBD, discern differences in IL-23 binding among IL-23p19–targeted therapies, assess the safety and efficacy of IL-23p19–targeted therapies for the treatment of IBD, and explore when to incorporate IL-23p19–targeted therapies into the management of patients with IBD.
Miguel Regueiro earned his bachelor’s degree at the University of Pennsylvania, his medical degree at Drexel (Hahnemann) University and completed his internal medicine internship, residency, and clinical and research fellowship training in gastroenterology at Harvard Medical School’s Beth Israel Hospital.
Dr. Regueiro was Professor of Medicine and Clinical and Translational Science at the University of Pittsburgh School of Medicine from 2000 to 2018. There he served as the IBD Clinical Medical Director, Senior Medical Lead of Specialty Medical Homes, was Professor with Tenure, and honored as the UPMC Endowed Chair for Patient Centered Care in Inflammatory Bowel Diseases.
Dr. Regueiro is currently the Chair of the Department of Gastroenterology and Hepatology and Chair of the Digestive Disease and Surgery Institute at Cleveland Clinic in Ohio. He serves as Medical Co- Chair of Digestive Disease and Surgical Institute Research Governance committee and is Professor of Medicine at the Lerner College of Medicine, Cleveland Clinic.
Dr. Regueiro’s main clinical and research interest is Inflammatory Bowel Diseases with a focus on the natural course of these diseases and postoperative prevention of Crohn’s disease. Recently, he has been involved in transformative medicine initiatives and developing new models of healthcare, including the first-of-its kind specialty medical home for IBD. Dr. Regueiro is investigating alternative models of care in population-based health that integrates patients, payers, providers, pharmaceutical industry, and other facets of healthcare delivery around these novel programs.